We are live on !
Find out more
Moors & Cabot Portfolio holdings
AUM
$2.65B
Turnover
11.39%
1-Year Est. Return
29.91%
Moors & Cabot is a full-service wealth management firm that dates to 1890, when John F. Moors and Charles Cabot started it in Boston. The two founders set it up to manage their own families' investments and those of their friends. It offers investment management, planning and advice for major life events, and runs its own insurance and annuities department. Michael Hildreth, its president and chief executive, is also one of its owners.
This Fund
S&P 500
This Quarter Est. Return
+3.94%
1 Year Est. Return
+29.91%
3 Year Est. Return
+133.86%
5 Year Est. Return
+167.35%
10 Year Est. Return
+483.58%
AUM
$691M
AUM Growth
+$89.6M
(+15%)
Cap. Flow
+$70.8M
Cap. Flow % of AUM
Cap. Flow %
10.23%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
565
New
53
Increased
300
Reduced
124
Closed
26
Avg Time Held
Equity + Options
2.2
years
Top 10 Avg Time Held
Equity + Options
2.2
years
Top 20 Avg Time Held
Equity + Options
2.4
years
Avg Time Held Equity only
2.3
years
Top 10 Avg Time Held Equity only
2.2
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$4.05M |
| 2 |
Apple
AAPL
|
+$2.61M |
| 3 |
Oneok
OKE
|
+$2.54M |
| 4 |
Johnson & Johnson
JNJ
|
+$2.19M |
| 5 |
Amazon
AMZN
|
+$2.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$3.97M |
| 2 |
OKS
Oneok Partners LP
OKS
|
+$2.4M |
| 3 |
Invesco National AMT-Free Municipal Bond ETF
PZA
|
+$1.45M |
| 4 |
W.W. Grainger
GWW
|
+$1.2M |
| 5 |
Newell Brands
NWL
|
+$859K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.08% |
| 2 | Energy | 14.06% |
| 3 | Industrials | 11.94% |
| 4 | Technology | 9.74% |
| 5 | Miscellaneous | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Johnson & Johnson
JNJ
$675B
| $16.5M | 2.39% |
126,785
+16,504
| +15% | +$2.19M |
2014 Q1
14 quarters
|
|
2
ExxonMobil
XOM
$680B
| $14.4M | 2.09% |
176,308
+25,794
| +17% | +$2.05M |
2014 Q1
14 quarters
|
|
|
3
Apple
AAPL
$5.17T
| $12.9M | 1.86% |
334,380
+67,368
| +25% | +$2.61M |
2014 Q1
14 quarters
|
|
4
Procter & Gamble
PG
$389B
| $12.3M | 1.78% |
135,738
+14,261
| +12% | +$1.3M |
2014 Q1
14 quarters
|
|
5
AT&T
T
$150B
| $11.4M | 1.65% |
384,155
+55,951
| +17% | +$1.59M |
2014 Q1
14 quarters
|
|
6
GE Aerospace
GE
$356B
| $10.8M | 1.56% |
93,072
+10,227
| +12% | +$1.24M |
2014 Q1
14 quarters
|
|
7
Microsoft
MSFT
$3.87T
| $10.2M | 1.47% |
136,915
+19,834
| +17% | +$1.45M |
2014 Q1
14 quarters
|
|
8
PepsiCo
PEP
$196B
| $9.9M | 1.44% |
89,131
+12,083
| +16% | +$1.4M |
2014 Q1
14 quarters
|
|
9
Verizon
VZ
$193B
| $9.7M | 1.4% |
196,080
+29,858
| +18% | +$1.4M |
2014 Q1
14 quarters
|
|
10
Chevron
CVX
$416B
| $8.66M | 1.25% |
73,341
+12,834
| +21% | +$1.4M |
2014 Q1
14 quarters
|
|
11
Enterprise Products Partners
EPD
$80.1B
| $8.31M | 1.2% |
319,218
+11,685
| +4% | +$309K |
2014 Q1
14 quarters
|
|
12
JPMorgan Chase
JPM
$912B
| $7.71M | 1.12% |
80,667
+20,708
| +35% | +$1.91M |
2014 Q1
14 quarters
|
|
|
13
DuPont de Nemours
DD
$20.6B
| $7.41M | 1.07% |
42,246
+24,257
| +135% | +$4.05M |
2014 Q1
14 quarters
|
|
14
Pfizer
PFE
$168B
| $7.05M | 1.02% |
207,974
+15,009
| +8% | +$482K |
2014 Q1
14 quarters
|
|
15
Intel
INTC
$332B
| $6.44M | 0.93% |
169,291
+38,108
| +29% | +$1.35M |
2014 Q1
14 quarters
|
|
|
MMP
16
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $6.42M | 0.93% |
90,334
+543
| +0.6% | +$37.5K |
2014 Q1
14 quarters
|
|
17
RTX Corp
RTX
$272B
| $6.27M | 0.91% |
85,660
+18,326
| +27% | +$1.36M |
2014 Q1
14 quarters
|
|
18
DELISTED
Psychemedics Corporation
PMD
| $6.22M | 0.9% |
337,060
+19,763
| +6% | +$435K |
2014 Q1
14 quarters
|
|
19
Merck
MRK
$363B
| $6.16M | 0.89% |
100,929
+22,740
| +29% | +$1.38M |
2014 Q1
14 quarters
|
|
20
Amgen
AMGN
$253B
| $5.6M | 0.81% |
29,988
+1,428
| +5% | +$253K |
2014 Q1
14 quarters
|
|
21
BP
BP
$117B
| $5.27M | 0.76% |
151,803
-14,654
| -9% | -$466K |
2014 Q1
14 quarters
|
|
22
Bristol-Myers Squibb
BMY
$129B
| $5.12M | 0.74% |
80,309
+4,195
| +6% | +$245K |
2014 Q1
14 quarters
|
|
23
CVS Health
CVS
$115B
| $4.85M | 0.7% |
59,851
+6,715
| +13% | +$531K |
2014 Q1
14 quarters
|
|
24
Eaton
ETN
$140B
| $4.79M | 0.69% |
62,275
+14,444
| +30% | +$1.09M |
2014 Q1
14 quarters
|
|
25
3M
MMM
$97.4B
| $4.76M | 0.69% |
27,113
+6,696
| +33% | +$1.16M |
2014 Q1
14 quarters
|
|
Similar funds
FFH
Moors & Cabot's Q3 2017 Portfolio in Review
As of Q3 2017, Moors & Cabot held 565 positions worth $691M, up 15% from $602M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Moors & Cabot deployed $70.8M of net new capital in Q3 2017, opening 53 new positions and adding to 300 existing holdings. Its largest new stake was Oneok: 47,060 shares worth $2.61M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was General Mills, an estimated $799K trimmed.
- Moors & Cabot's largest Q3 2017 buy was Oneok: 47,060 shares worth $2.61M.
- Moors & Cabot added most to DuPont de Nemours in Q3 2017, an estimated $4.05M increase.
- Moors & Cabot's biggest Q3 2017 reduction was General Mills, cutting an estimated $799K.
- Moors & Cabot fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $3.97M.
- Moors & Cabot's ten largest holdings make up 17% of its $691M portfolio in Q3 2017.
- Moors & Cabot opened 53 new positions and closed 26 in Q3 2017.
- Moors & Cabot's portfolio value rose 15% quarter-over-quarter to $691M.
Based on Moors & Cabot's 13F filing for Q3 2017, filed 16 Nov 2017.